-
1
-
-
84862288061
-
-
Gaucher Disease, in: D. Valle (Ed.), The Online Metabolic and Molecular Bases of Inherited Disease, McGraw-Hill, (Chapter 146).
-
G.A. Grabowski, G.A. Petsko, E.H. Kolodny, Gaucher Disease, in: D. Valle (Ed.), The Online Metabolic and Molecular Bases of Inherited Disease, McGraw-Hill, 2010 (Chapter 146).
-
(2010)
-
-
Grabowski, G.A.1
Petsko, G.A.2
Kolodny, E.H.3
-
2
-
-
78650352199
-
A reappraisal of Gaucher disease-diagnosis and disease management algorithms
-
Mistry P.K., Cappellini M.D., Lukina E., Ozsan H., Mach Pascual S., Rosenbaum H., Helena Solano M., Spigelman Z., Villarrubia J., Watman N.P., Massenkeil G. A reappraisal of Gaucher disease-diagnosis and disease management algorithms. Am. J. Hematol. 2011, 86:110-115.
-
(2011)
Am. J. Hematol.
, vol.86
, pp. 110-115
-
-
Mistry, P.K.1
Cappellini, M.D.2
Lukina, E.3
Ozsan, H.4
Mach Pascual, S.5
Rosenbaum, H.6
Helena Solano, M.7
Spigelman, Z.8
Villarrubia, J.9
Watman, N.P.10
Massenkeil, G.11
-
3
-
-
84862776523
-
Genome-wide association study of N370S homozygous Gaucher disease reveals the candidacy of CLN8 gene as a genetic modifier contributing to extreme phenotypic variation
-
Zhang C.K., Stein P.B., Liu J., Wang Z., Yang R., Cho J.H., Gregersen P.K., Aerts J.M., Zhao H., Pastores G.M., Mistry P.K. Genome-wide association study of N370S homozygous Gaucher disease reveals the candidacy of CLN8 gene as a genetic modifier contributing to extreme phenotypic variation. Am. J. Hematol. 2012, 87:377-383.
-
(2012)
Am. J. Hematol.
, vol.87
, pp. 377-383
-
-
Zhang, C.K.1
Stein, P.B.2
Liu, J.3
Wang, Z.4
Yang, R.5
Cho, J.H.6
Gregersen, P.K.7
Aerts, J.M.8
Zhao, H.9
Pastores, G.M.10
Mistry, P.K.11
-
4
-
-
84861217290
-
-
analysis P.D.I.T.1.G.D.D.T.G.B.O.G.D.M.P.B.I.G.
-
Lo S.M., Choi M., Liu J., Jain D., Boot R.G., Kallemeijn W.W., Aerts J.M., Pashankar F., Kupfer G.M., Mane S., Lifton R.P., Mistry P.K., analysis Phenotypic diversity in type 1 Gaucher disease: discovering the genetic basis of Gaucher disease/hematological malignancy phenotype by individual genome Blood 2012, 119:4731-4740.
-
(2012)
Blood
, vol.119
, pp. 4731-4740
-
-
Lo, S.M.1
Choi, M.2
Liu, J.3
Jain, D.4
Boot, R.G.5
Kallemeijn, W.W.6
Aerts, J.M.7
Pashankar, F.8
Kupfer, G.M.9
Mane, S.10
Lifton, R.P.11
Mistry, P.K.12
-
5
-
-
80052672242
-
Gaucher disease and cancer: concept and controversy
-
F.Y. Choy, T.N. Campbell, Gaucher disease and cancer: concept and controversy, Int. J. Cell. Biol. 2011 (2011) 150450.
-
(2011)
Int. J. Cell. Biol.
, Issue.2011
, pp. 150450
-
-
Choy, F.Y.1
Campbell, T.N.2
-
6
-
-
64549119033
-
The underrecognized progressive nature of N370S Gaucher disease and assessment of cancer risk in 403 patients
-
Taddei T.H., Kacena K.A., Yang M., Yang R., Malhotra A., Boxer M., Aleck K.A., Rennert G., Pastores G.M., Mistry P.K. The underrecognized progressive nature of N370S Gaucher disease and assessment of cancer risk in 403 patients. Am. J. Hematol. 2009, 84:208-214.
-
(2009)
Am. J. Hematol.
, vol.84
, pp. 208-214
-
-
Taddei, T.H.1
Kacena, K.A.2
Yang, M.3
Yang, R.4
Malhotra, A.5
Boxer, M.6
Aleck, K.A.7
Rennert, G.8
Pastores, G.M.9
Mistry, P.K.10
-
7
-
-
0028783597
-
Natural autoantibodies in sera of patients with Gaucher's disease
-
Shoenfeld Y., Beresovski A., Zharhary D., Tomer Y., Swissa M., Sela E., Zimran A., Zevin S., Gilburd B., Blank M. Natural autoantibodies in sera of patients with Gaucher's disease. J. Clin. Immunol. 1995, 15:363-372.
-
(1995)
J. Clin. Immunol.
, vol.15
, pp. 363-372
-
-
Shoenfeld, Y.1
Beresovski, A.2
Zharhary, D.3
Tomer, Y.4
Swissa, M.5
Sela, E.6
Zimran, A.7
Zevin, S.8
Gilburd, B.9
Blank, M.10
-
8
-
-
15244348524
-
Gaucher disease and parkinsonism
-
Sidransky E. Gaucher disease and parkinsonism. Mol. Genet. Metab. 2005, 84:302-304.
-
(2005)
Mol. Genet. Metab.
, vol.84
, pp. 302-304
-
-
Sidransky, E.1
-
9
-
-
78650827299
-
Osteopenia in Gaucher disease develops early in life: response to imiglucerase enzyme therapy in children, adolescents and adults
-
Mistry P.K., Weinreb N.J., Kaplan P., Cole J.A., Gwosdow A.R., Hangartner T. Osteopenia in Gaucher disease develops early in life: response to imiglucerase enzyme therapy in children, adolescents and adults. Blood Cells Mol. Dis. 2011, 46:66-72.
-
(2011)
Blood Cells Mol. Dis.
, vol.46
, pp. 66-72
-
-
Mistry, P.K.1
Weinreb, N.J.2
Kaplan, P.3
Cole, J.A.4
Gwosdow, A.R.5
Hangartner, T.6
-
10
-
-
78650614891
-
Glucocerebrosidase gene-deficient mouse recapitulates Gaucher disease displaying cellular and molecular dysregulation beyond the macrophage
-
Mistry P.K., Liu J., Yang M., Nottoli T., McGrath J., Jain D., Zhang K., Keutzer J., Chuang W.L., Mehal W.Z., Zhao H., Lin A., Mane S., Liu X., Peng Y.Z., Li J.H., Agrawal M., Zhu L.L., Blair H.C., Robinson L.J., Iqbal J., Sun L., Zaidi M. Glucocerebrosidase gene-deficient mouse recapitulates Gaucher disease displaying cellular and molecular dysregulation beyond the macrophage. Proc. Natl. Acad. Sci. USA 2010, 107:19473-19478.
-
(2010)
Proc. Natl. Acad. Sci. USA
, vol.107
, pp. 19473-19478
-
-
Mistry, P.K.1
Liu, J.2
Yang, M.3
Nottoli, T.4
McGrath, J.5
Jain, D.6
Zhang, K.7
Keutzer, J.8
Chuang, W.L.9
Mehal, W.Z.10
Zhao, H.11
Lin, A.12
Mane, S.13
Liu, X.14
Peng, Y.Z.15
Li, J.H.16
Agrawal, M.17
Zhu, L.L.18
Blair, H.C.19
Robinson, L.J.20
Iqbal, J.21
Sun, L.22
Zaidi, M.23
more..
-
11
-
-
33749335282
-
The Connectivity Map: using gene-expression signatures to connect small molecules, genes, and disease
-
Lamb J., Crawford E.D., Peck D., Modell J.W., Blat I.C., Wrobel M.J., Lerner J., Brunet J.P., Subramanian A., Ross K.N., Reich M., Hieronymus H., Wei G., Armstrong S.A., Haggarty S.J., Clemons P.A., Wei R., Carr S.A., Lander E.S., Golub T.R. The Connectivity Map: using gene-expression signatures to connect small molecules, genes, and disease. Science 2006, 313:1929-1935.
-
(2006)
Science
, vol.313
, pp. 1929-1935
-
-
Lamb, J.1
Crawford, E.D.2
Peck, D.3
Modell, J.W.4
Blat, I.C.5
Wrobel, M.J.6
Lerner, J.7
Brunet, J.P.8
Subramanian, A.9
Ross, K.N.10
Reich, M.11
Hieronymus, H.12
Wei, G.13
Armstrong, S.A.14
Haggarty, S.J.15
Clemons, P.A.16
Wei, R.17
Carr, S.A.18
Lander, E.S.19
Golub, T.R.20
more..
-
12
-
-
78651067048
-
Global gene expression profile progression in Gaucher disease mouse models
-
Xu Y.H., Jia L., Quinn B., Zamzow M., Stringer K., Aronow B., Sun Y., Zhang W., Setchell K.D., Grabowski G.A. Global gene expression profile progression in Gaucher disease mouse models. BMC Genom. 2011, 12:20.
-
(2011)
BMC Genom.
, vol.12
, pp. 20
-
-
Xu, Y.H.1
Jia, L.2
Quinn, B.3
Zamzow, M.4
Stringer, K.5
Aronow, B.6
Sun, Y.7
Zhang, W.8
Setchell, K.D.9
Grabowski, G.A.10
-
13
-
-
84862278528
-
The Gaucher disease gene GBA functions in immune regulation
-
USA, in press.
-
J. Liu, S. Halene, M. Yang, J. Iqbal, R. Yang, W.Z. Mehal, W.L. Chuang, D. Jain, L. Sun, M. Zaidi, P.K. Mistry, The Gaucher disease gene GBA functions in immune regulation, Proc. Natl. Acad. Sci. USA, in press.
-
Proc. Natl. Acad. Sci.
-
-
Liu, J.1
Halene, S.2
Yang, M.3
Iqbal, J.4
Yang, R.5
Mehal, W.Z.6
Chuang, W.L.7
Jain, D.8
Sun, L.9
Zaidi, M.10
Mistry, P.K.11
-
14
-
-
41049113128
-
Gaucher disease: unmet treatment needs
-
Mehta A. Gaucher disease: unmet treatment needs. Acta Paediatr. Suppl. 2008, 97:83-87.
-
(2008)
Acta Paediatr. Suppl.
, vol.97
, pp. 83-87
-
-
Mehta, A.1
-
15
-
-
0029135190
-
Pathological findings in Gaucher disease type 2 patients following enzyme therapy
-
Bove K.E., Daugherty C., Grabowski G.A. Pathological findings in Gaucher disease type 2 patients following enzyme therapy. Hum. Pathol. 1995, 26:1040-1045.
-
(1995)
Hum. Pathol.
, vol.26
, pp. 1040-1045
-
-
Bove, K.E.1
Daugherty, C.2
Grabowski, G.A.3
-
16
-
-
33748541288
-
The biology of the Gaucher cell: the cradle of human chitinases
-
Bussink A.P., van Eijk M., Renkema G.H., Aerts J.M., Boot R.G. The biology of the Gaucher cell: the cradle of human chitinases. Int. Rev. Cytol. 2006, 252:71-128.
-
(2006)
Int. Rev. Cytol.
, vol.252
, pp. 71-128
-
-
Bussink, A.P.1
van Eijk, M.2
Renkema, G.H.3
Aerts, J.M.4
Boot, R.G.5
-
17
-
-
79951776429
-
Role of chitin and chitinase/chitinase-like proteins in inflammation, tissue remodeling, and injury
-
Lee C.G., Da Silva C.A., Dela Cruz C.S., Ahangari F., Ma B., Kang M.J., He C.H., Takyar S., Elias J.A. Role of chitin and chitinase/chitinase-like proteins in inflammation, tissue remodeling, and injury. Annu. Rev. Physiol. 2011, 73:479-501.
-
(2011)
Annu. Rev. Physiol.
, vol.73
, pp. 479-501
-
-
Lee, C.G.1
Da Silva, C.A.2
Dela Cruz, C.S.3
Ahangari, F.4
Ma, B.5
Kang, M.J.6
He, C.H.7
Takyar, S.8
Elias, J.A.9
-
18
-
-
80051831092
-
Computational repositioning of the anticonvulsant topiramate for inflammatory bowel disease
-
Dudley J.T., Sirota M., Shenoy M., Pai R.K., Roedder S., Chiang A.P., Morgan A.A., Sarwal M.M., Pasricha P.J., Butte A.J. Computational repositioning of the anticonvulsant topiramate for inflammatory bowel disease. Sci. Transl. Med. 2011, 3:76-96.
-
(2011)
Sci. Transl. Med.
, vol.3
, pp. 76-96
-
-
Dudley, J.T.1
Sirota, M.2
Shenoy, M.3
Pai, R.K.4
Roedder, S.5
Chiang, A.P.6
Morgan, A.A.7
Sarwal, M.M.8
Pasricha, P.J.9
Butte, A.J.10
-
19
-
-
84859633464
-
Connectivity mapping identifies HDAC inhibitors for the treatment of t(4;11)-positive infant acute lymphoblastic leukemia
-
Stumpel D.J., Schneider P., Seslija L., Osaki H., Williams O., Pieters R., Stam R.W. Connectivity mapping identifies HDAC inhibitors for the treatment of t(4;11)-positive infant acute lymphoblastic leukemia. Leukemia 2012, 26:682-692.
-
(2012)
Leukemia
, vol.26
, pp. 682-692
-
-
Stumpel, D.J.1
Schneider, P.2
Seslija, L.3
Osaki, H.4
Williams, O.5
Pieters, R.6
Stam, R.W.7
-
20
-
-
61849179838
-
Diltiazem, a L-type Ca(2+) channel blocker, also acts as a pharmacological chaperone in Gaucher patient cells
-
Rigat B., Mahuran D. Diltiazem, a L-type Ca(2+) channel blocker, also acts as a pharmacological chaperone in Gaucher patient cells. Mol. Genet. Metab. 2009, 96:225-232.
-
(2009)
Mol. Genet. Metab.
, vol.96
, pp. 225-232
-
-
Rigat, B.1
Mahuran, D.2
|